Laura Mildenberger Insider Sell Transaction

Sale totalling $796,494 U.S Dollars was disclosed online in a form submitted to the Security and Exchange Commission on 22/05/2015. According to which, Laura Mildenberger, the Chief People Ofcr – Kidney Care of DaVita HealthCare Partners Inc (NYSE:DVA) 84.09 +0.60 0.72% also an insider of the -listed Davita Healthcare Partners Inc had sold precisely 9,579 shares – ( at $83.2 for share ). In the last month, she also unloaded 461 shares with value $38,148 USD. Laura Mildenberger now has ownership of 6,273 shares or 0.00% of Davita Healthcare Partners Inc’s market cap.

Davita Healthcare Partners Inc Stock Rating, Sentiment and Fundamentals

In addition, the fifteen equity specialist analysts that are in charge of Davita Healthcare Partners Inc, forecast $3.77 EPS in 2015. This indicates a PE ratio of 22.15 and growth rate YoY of 12.50% with Laura Mildenberger leading. It is difficult to make conclusions about Davita Healthcare Partners Inc’s future just from Laura Mildenberger’s sale because in this filing, the insider also revealed option transactions. In the form, it was reported that Laura exercised options for 20,000 shares with average price 43.4, worth 867,000.

* Read How Our Stock Ratings System Works

The stock price of Davita Healthcare Partners Inc has climbed 16.75% compared to the price last 200 days. And this smooth and strong up trend looks set to continue. Because of our well-know stocks time-momentum system which is shown on the chart below is flashing Buy, Octafinance can’t rate the stock SELL as Laura did with her trade.

Price Chart of Davita Healthcare Partners NYSE:DVA Stock

Source: RightEdgeSystems, Yahoo Split & Dividend Adjusted Data and OctaFinance Interpretations

Hedge Funds Ownership

Data gathered from 13F SEC filings, disclose that 468 institutional investors and hedge funds owned shares of Davita Healthcare Partners Inc. In the last quarter, the company in focus had 197.62% institutional ownership. That is a very high interest. They increased by 248.54 million the total shares they hold. As of that quarter these professional stock owners owned 424.89 million shares. There were 30 funds that closed their positions and 158 that reduced them. A total of 50 funds opened new positions in Davita Healthcare Partners Inc and 189 increased their holdings.

Of them, 16 have the stock in their Top 10. These funds are: Foundation Asset Management Lp, Swift Run Capital Management Llc, Summit Partners L P, Timessquare Capital Management Llc, Cognios Capital Llc, Triple Frond Partners Llc, Hikari Power Ltd, Gates Capital Management Inc., Hikari Tsushin Inc., Roundview Capital Llc.

Bluestein R H & Co is the most positive hedge fund on Davita Healthcare Partners Inc, with ownership of 10,650 shares as of Q4 2014 for 0.05% of the fund’s portfolio. Dock Street Asset Management Inc is another positive investment manager owning 57,383 shares of the company or 2.29% of their stocks portfolio. The stock is also 1.06% of the fund’s AUM. The California-based fund First Republic Investment Management Inc. have 0.01% of their stock portfolio invested in the company for 7,274 shares. Moreover, Foster Dykema Cabot & Co Inc Ma revealed it had acquired a stake worth 2.05% of the fund’s stock portfolio in the company. Geneva Advisors Llc was also a notable follower of the company, possessing 5,435 shares. Davita Healthcare Partners Inc is 0.01% of the fund’s stock portfolio.

DaVita HealthCare Partners NYSE:DVA Company Profile

DaVita HealthCare Partners Inc. offers kidney care and manages and operates medical groups. DaVita HealthCare Partners Inc. operates through DaVita Kidney Care and HealthCare Partners (HCP). The Company’s services include outpatient hemodialysis services, hospital inpatient hemodialysis services, Home-based hemodialysis services, ESRD laboratory services and management services. It operates or provides administrative services through a network of outpatient dialysis centers in the United States that are designed for outpatient hemodialysis. The Company provides hospital inpatient hemodialysis services, excluding physician services, to patients in hospitals throughout the United States. DaVita Kidney Care is a provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. HCP manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, and Florida.

Davita Healthcare Partners Inc was formed in Delaware on 1994-04-04. The company has 57900 employees. At the moment its market capitalization is: $18.08 billion and it has 216.55 million outstanding shares. Now there are 86.57% shareholders and the institutional ownership stands at 86.57%. The stock closed at $83.49 yesterday and it had average 2 days volume of 198303 shares. It is down from the 30 days average shares volume of 240783. Davita Healthcare Partners Inc has a 52 weeks low of $68.10 and a 52weeks high of $85.17. The stock price is above the 200 days Simple moving average. Davita Healthcare Partners Inc last issued its quarterly earnings information on 05/04/2015. The company reported 0.86 EPS for the quarter, above the consensus estimate of 0.85 by 0.01. The company had a revenue of 3.29 billion for 3/31/2015 and 3.33 billion for 12/31/2014. Therefore, the revenue was -40,052,000 down.

* Stock Appreciation Rights granted on 4/13/2011 and vesting 50% each on 4/13/2014 and 4/13/2015.

Tagged: DaVita HealthCare Partners - (NYSE:DVA)Laura Mildenberger

...